Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 52

Sort by

Sort Order Select

Journal Articles

Impact of Letermovir Prophylaxis for Cytomegalovirus Reactivation on Post-Transplant Outcomes 100 Days before and after Allogeneic Hematopoietic Cell Transplantation

Blood (2023) 142 (Supplement 1): 4898.

https://doi.org/10.1182/blood-2023-180906

Published: 2023

Journal Articles

Impact of Early Anti-Cytomegalovirus Therapy on the Incidence of Chronic Graft-Versus-Host Disease

Kotaro Miyao, Makoto Murata, Tetsuya Nishida, Yukiyasu Ozawa, Naoyuki Uchida, Takahiro Fukuda, Noriko Doki, Tetsuya Eto, Toshiro Kawakita, Yasuo Mori, Satoru Takada, Hiroyuki Ohigashi, Masatsugu Tanaka, Yoshinobu Kanda, Ken-ichi Matsuoka, Fumihiko Ishimaru, Yoshiko Atsuta, Junya Kanda, Seitaro Terakura

Blood (2023) 142 (Supplement 1): 6993.

https://doi.org/10.1182/blood-2023-178592

Published: 2023

Journal Articles

Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect

Blood (2023) 142 (11): 1008–1021.

https://doi.org/10.1182/blood.2023019799

Published: 2023

Includes: Supplemental data

Journal Articles

The Novel Scoring System to Personalize the Conditioning Intensity in Elderly Patients

Yu Akahoshi, Yuma Tada, Emiko Sakaida, Machiko Kusuda, Noriko Doki, Naoyuki Uchida, Takahiro Fukuda, Masatsugu Tanaka, Masashi Sawa, Yuta Katayama, Ken-ichi Matsuoka, Yukiyasu Ozawa, Makoto Onizuka, Junya Kanda, Yoshinobu Kanda, Yoshiko Atsuta, Hideki Nakasone

Blood (2022) 140 (Supplement 1): 2123–2125.

https://doi.org/10.1182/blood-2022-160037

Published: 2022

Journal Articles

Donor Selection Considering Donor Age in Hematopoietic Cell Transplant Recipients 50-75 Years of Age

Blood (2022) 140 (Supplement 1): 10598–10600.

https://doi.org/10.1182/blood-2022-158213

Published: 2022

Journal Articles

International Collaborative Study to Compare the Prognosis for Acute Leukemia Patients Transplanted with Intensified Myeloablative Regimens

Blood (2022) 140 (Supplement 1): 4711–4713.

https://doi.org/10.1182/blood-2022-160305

Published: 2022

Journal Articles

HLA-B Leader Dimorphism Impacts on Outcomes of HLA-Matched Related/Unrelated Transplantation: Analysis of the Japanese Society for Transplantation and Cellular Therapy

Minoru Kanaya, Yasuo Morishima, Nobuyoshi Arima, Masahiro Hirayama, Souichi Shiratori, Noriko Doki, Yukiyasu Ozawa, Takahiro Fukuda, Masatsugu Tanaka, Masashi Sawa, Satoru Takada, Shuichi Ota, Toshiro Kawakita, Junya Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Satoko Morishima

Blood (2021) 138 (Supplement 1): 2919.

https://doi.org/10.1182/blood-2021-144669

Published: 2021

Journal Articles

Impact of Human Leukocyte Antigen Epitope Matching on Outcomes after Unrelated Bone Marrow Transplantation

Makoto Iwasaki, Junya Kanda, Hidenori Tanaka, Takero Shindo, Noriko Doki, Takahiro Fukuda, Yukiyasu Ozawa, Tetsuya Eto, Naoyuki Uchida, Yuta Katayama, Keisuke Kataoka, Makoto Onizuka, Yoshinobu Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Satoko Morishima

Blood (2021) 138 (Supplement 1): 3914.

https://doi.org/10.1182/blood-2021-145686

Published: 2021

Journal Articles

Comparison of Myeloablative Versus Reduced-Intensity Fludarabine/Busulfan Regimen in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Shuhei Kurosawa, Yoshimitsu Shimomura, Hidehiro Itonaga, Yuho Najima, Takeshi Kobayashi, Yukiyasu Ozawa, Yoshinobu Kanda, Shinichi Kako, Toshiro Kawakita, Ken-Ichi Matsuoka, Yumiko Maruyama, Shuichi Ota, Hideyuki Nakazawa, Kazunori Imada, Takafumi Kimura, Junya Kanda, Takahiro Fukuda, Yoshiko Atsuta, Ken Ishiyama

Blood (2021) 138 (Supplement 1): 3692.

https://doi.org/10.1182/blood-2021-144689

Published: 2021

Journal Articles

Optimal Interval for Detection of Molecular Relapse after Stop of Tyrosine Kinase Inhibitor (TKI) in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) Caliculated By Kinetics of BCR-ABL Transcripts

Koichi Miyamura, MD, Masahide Osaki, MD, Tatsunori Goto, MD PhD, Takanobu Morishita, MD PhD, Yukiyasu Ozawa, MD PhD

Blood (2020) 136 (Supplement 1): 21.

https://doi.org/10.1182/blood-2020-141480

Published: 2020

Journal Articles

Significance of Marker Chromosome on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for AML

Kyoko Fuse, MD PhD, Masayoshi Masuko, MD PhD, Shohei Mizuno, MD PhD, Kaito Harada, MD, Naoyuki Uchida, MD PhD, Noriko Doki, MD PhD, Takahiro Fukuda, Masatsugu Tanaka, MD, Yukiyasu Ozawa, MD PhD, Kazuhiro Ikegame, MD PhD, Tetsuya Eto, MD PhD, Yoshinobu Kanda, MD PhD, Tatsuo Ichinohe, Yoshiko Atsuta, MD PhD, Masamitsu Yanada, MD PhD

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-138979

Published: 2020

Journal Articles

Prospective Evaluation of Alternative Donor from Unrelated Volunteer Donor and Cord Blood in Adult Acute Leukemia and Myelodysplastic Syndrome: No Difference between Unrelated Donor and Cord Blood

Blood (2019) 134 (Supplement_1): 4587.

https://doi.org/10.1182/blood-2019-124634

Published: 2019

Journal Articles

Impact of Graft-Versus-Host Disease and Graft-Versus-Leukemia Effect Based on Minimal Residual Disease in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Yu Akahoshi, MD, Aiko Igarashi, MD, Takahiro Fukuda, Naoyuki Uchida, MD PhD, Masatsugu Tanaka, MD, Yukiyasu Ozawa, MD PhD, Yoshinobu Kanda, MD PhD, Makoto Onizuka, MD PhD, Tatsuo Ichinohe, Junji Tanaka, MD PhD, Yoshiko Atsuta, MD PhD, Shinichi Kako, MD

Blood (2019) 134 (Supplement_1): 4522.

https://doi.org/10.1182/blood-2019-123983

Published: 2019

Journal Articles

Difference in the Donor Selection Priority in Allogeneic Hematopoietic Stem Cell Transplantation According to Patient Age

Koji Kawamura, Junya Kanda, MD, Sachiko Seo, MDPhD, Fumihiko Kimura, MD PhD, Masahiro Hirayama, MD PhD, Naoyuki Uchida, MD PhD, Noriko Doki, MD PhD, Takahiro Fukuda, Yukiyasu Ozawa, MD PhD, Yuta Katayama, MD PhD, Minoko Takanashi, MD PhD, Yoshiko Atsuta, MD PhD, Yoshinobu Kanda, MD PhD

Blood (2019) 134 (Supplement_1): 46.

https://doi.org/10.1182/blood-2019-125032

Published: 2019

Journal Articles

Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Myeloid Leukemia in Japan

Shohei Mizuno, MD PhD, Masamitsu Yanada, Koji Kawamura, Shingo Yano, MD PhD, Masayoshi Masuko, MD, Naoyuki Uchida, MD PhD, Yukiyasu Ozawa, MD PhD, Koji Iwato, Kazuteru Ohashi, MD PhD, Kazuhiro Ikegame, MD PhD, Sung-Won Kim, MD PhD, Masatsugu Tanaka, MD, Tetsuya Eto, MD PhD, Yoshinobu Kanda, MD PhD, Takahiro Fukuda, Yoshiko Atsuta, MD PhD, Akiyoshi Takami, MD

Blood (2019) 134 (Supplement_1): 2045.

https://doi.org/10.1182/blood-2019-122801

Published: 2019

Journal Articles

Prospective Evaluation of Allogeneic HSCT at the First Remission for Younger Adults with FLT3 -ITD Positive Acute Myeloid Leukemia: The JALSG AML209-FLT3-SCT Study

Blood (2019) 134 (Supplement_1): 1328.

https://doi.org/10.1182/blood-2019-124394

Published: 2019

Journal Articles

Development of Predictive Biomarker and Optimal Treatment Strategy with FLT3 Inhibitors in Acute Myeloid Leukemia

Jeong Hui Kim, Yasuhiko Harada, MD PhD, Yuichi Ishikawa, MD PhD, Naomi Kawashima, MD PhD, Marie Nakashima, MD, Yoko Ushijima, MD PhD, Takahiro Nishiyama, MD PhD, Tatsunori Goto, MD PhD, Nobuaki Fukushima, MD PhD, Rika Kihara, MD PhD, Tomohiro Kajiguchi, MD PhD, Koichi Watamoto, MD PhD, Akio Kohno, MD PhD, Kunio Kitamura, MD PhD, Yukiyasu Ozawa, MD PhD, Hitoshi Kiyoi, MD PhD

Blood (2019) 134 (Supplement_1): 1418.

https://doi.org/10.1182/blood-2019-127610

Published: 2019

Journal Articles

Dasatinib-Based Two-Step Induction Prior to Allogeneic Hematopoietic Cell Transplantation for Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of the JALSG Ph+ALL213 Study

Blood (2019) 134 (Supplement_1): 743.

https://doi.org/10.1182/blood-2019-123382

Published: 2019

Journal Articles

Impact of Different Doses of Fludarabine in Fludarabine-Based Conditioning Regimen for Unrelated Bone Marrow Transplantation

Kodai Kuriyama, MD PhD, Shigeo Fuji, MD PhD, Noriko Doki, MD PhD, Yuta Katayama, MD PhD, Souichi Shiratori, Yukiyasu Ozawa, MD PhD, Takashi Ashida, MD PhD, Junya Kanda, MD, Takahiro Fukuda, Yoshiko Atsuta, MD PhD, Masao Ogata, MD PhD

Blood (2019) 134 (Supplement_1): 3258.

https://doi.org/10.1182/blood-2019-123926

Published: 2019

Journal Articles

Dynamics of Genetic Landscapes and Clonal Evolution between Patients and PDX Models in Acute Myeloid Leukemia

Naomi Kawashima, MD, Yuichi Ishikawa, MD PhD, Akimi Akashi, MS, Hikaru Hattori, MS, Yohei Yamaguchi, MD, Takahiro Nishiyama, MD PhD, Rika Kihara, MD PhD, Yukiyasu Ozawa, Hitoshi Kiyoi, MD PhD

Blood (2018) 132 (Supplement 1): 439.

https://doi.org/10.1182/blood-2018-99-114085

Published: 2018

NARROW

Impact of Letermovir Prophylaxis for Cytomegalovirus Reactivation on Post-Transplant Outcomes 100 Days before and after Allogeneic Hematopoietic Cell Transplantation

Impact of Early Anti-Cytomegalovirus Therapy on the Incidence of Chronic Graft-Versus-Host Disease

Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect

The Novel Scoring System to Personalize the Conditioning Intensity in Elderly Patients

Donor Selection Considering Donor Age in Hematopoietic Cell Transplant Recipients 50-75 Years of Age

International Collaborative Study to Compare the Prognosis for Acute Leukemia Patients Transplanted with Intensified Myeloablative Regimens

HLA-B Leader Dimorphism Impacts on Outcomes of HLA-Matched Related/Unrelated Transplantation: Analysis of the Japanese Society for Transplantation and Cellular Therapy

Impact of Human Leukocyte Antigen Epitope Matching on Outcomes after Unrelated Bone Marrow Transplantation

Comparison of Myeloablative Versus Reduced-Intensity Fludarabine/Busulfan Regimen in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Optimal Interval for Detection of Molecular Relapse after Stop of Tyrosine Kinase Inhibitor (TKI) in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) Caliculated By Kinetics of BCR-ABL Transcripts

Significance of Marker Chromosome on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for AML

Prospective Evaluation of Alternative Donor from Unrelated Volunteer Donor and Cord Blood in Adult Acute Leukemia and Myelodysplastic Syndrome: No Difference between Unrelated Donor and Cord Blood

Impact of Graft-Versus-Host Disease and Graft-Versus-Leukemia Effect Based on Minimal Residual Disease in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Difference in the Donor Selection Priority in Allogeneic Hematopoietic Stem Cell Transplantation According to Patient Age

Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Myeloid Leukemia in Japan

Prospective Evaluation of Allogeneic HSCT at the First Remission for Younger Adults with FLT3 -ITD Positive Acute Myeloid Leukemia: The JALSG AML209-FLT3-SCT Study

Development of Predictive Biomarker and Optimal Treatment Strategy with FLT3 Inhibitors in Acute Myeloid Leukemia

Dasatinib-Based Two-Step Induction Prior to Allogeneic Hematopoietic Cell Transplantation for Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of the JALSG Ph+ALL213 Study

Impact of Different Doses of Fludarabine in Fludarabine-Based Conditioning Regimen for Unrelated Bone Marrow Transplantation

Dynamics of Genetic Landscapes and Clonal Evolution between Patients and PDX Models in Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only